EP4029877
INTERLEUKIN-21 MUTEINS AND METHODS OF TREATMENT
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
3.8.2018EP published:
17.1.2024EP application number:
21217086.4
EPO information:
European Patent Register
Max expiry date:
2.8.2038
Title in English:
INTERLEUKIN-21 MUTEINS AND METHODS OF TREATMENTLanguage of the patent:
English
Timeline
Today
3.8.2018EP application
17.1.2024EP Publication
Owner
Name:
Amgen Inc.Address:
One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US
Inventor
Name:
ALI, Khaled, M.K.Z.Address:
Thousand Oaks, CA 91320, US
Name:
AGRAWAL, Neeraj, JagdishAddress:
Thousand Oaks, CA 91320, US
Name:
KANNAN, GunasekaranAddress:
Thousand Oaks, CA 91320, US
Name:
FOLTZ, IanAddress:
Thousand Oaks, CA 91320, US
Name:
WANG, ZhulunAddress:
Thousand Oaks, CA 91320, US
Name:
BATES, DarenAddress:
Thousand Oaks, CA 91320, US
Name:
MOCK, MarissaAddress:
Thousand Oaks, CA 91320, US
Name:
TAKENAKA, ShunsekeAddress:
Thousand Oaks, CA 91320, US
Priority
Number:
201762540692 PDate:
3.8.2017Country:
US
Number:
201862616733 PDate:
12.1.2018Country:
US
Classification
Categories:
C07K 14/54, A61K 47/60, A61K 47/54